Saving changes...

Done

Error

Masqueraders of Anaphylaxis/Angioedema

Masqueraders of Anaphylaxis/Angioedema

Masqueraders of Anaphylaxis/Angioedema

Joseph H. Butterfield (MD FAAAAI), Melody C. Carter (MD FAAAAI), Marco Cicardi (MD), Dr. Kirk M. Dru
Joseph H. Butterfield (MD FAAAAI), Melody C. Carter (MD FAAAAI), Marco Cicardi (MD), Dr. Kirk M. Dru
on behalf of American Academy of Allergy Asthma & Immunology

$15.00 $ 15.00 $ 15.00

$15.00 $ 15.00 $ 15.00

$ 15.00 $ 15.00 $ 15.00
$ 15.00 $ 15.00 $ 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 29 Jun 2018
Expiry Date:

Last updated: 22 Aug 2018

Reference: 190481

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This course offers an in-depth explanation about Anaphylaxis/Angioedema.

Objectives

Describe uncommon causes of anaphylaxis-type symptoms and angioedema, including HAE, Gleich syndrome, familial tryptasemia/mast cell activation syndromes, idiopathic anaphylaxis and the systemic capillary leak syndrome
Upon completion of this session, participants should be able to describe uncommon causes of anaphylaxis-type symptoms and angioedema, including HAE, Gleich syndrome, familial tryptasemia/mast cell activation syndromes, idiopathic anaphylaxis and the systemic capillary leak syndrome.
Describe the cutting-edge research regarding the biology of rarer causes of anaphylactic symptoms and angioedema
Upon completion of this session, participants should be able to describe the cutting-edge research regarding the biology of rarer causes of anaphylactic symptoms and angioedema.
Discuss how this new information can be applied to understanding anaphylactoid symptoms in humans and how these cell types can potentially be modulated to treat patients
Upon completion of this session, participants should be able to discuss how this new information can be applied to understanding anaphylactoid symptoms in humans and how these cell types can potentially be modulated to treat patients.
Joseph H. Butterfield (MD FAAAAI), Melody C. Carter (MD FAAAAI), Marco Cicardi (MD), Dr. Kirk M. Dru

Author Information Play Video Bio

Joseph H. Butterfield (MD FAAAAI), Melody C. Carter (MD FAAAAI), Marco Cicardi (MD), Dr. Kirk M. Dru
on behalf of American Academy of Allergy Asthma & Immunology

Joseph H. Butterfield, MD FAAAAI, Mayo Clinic, Rochester, MN

Melody C. Carter, MD FAAAAI, National Institutes of Health/NIAID/LAD, Bethesda, MD

Marco Cicardi, MD, University of Milan, Milan, Italy

Dr. Kirk M. Druey, MD, NIH NIAID LAD, Bethesda, MD

Paneez Khoury, MD, National Institutes of Health, Bethesda, MD

Bruce L. Zuraw, MD, University of California, San Diego, San Diego, CA

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 2.50 Credits
  • California Board of Registered Nursing (CBRN)
  • 2.50 Hours

Faculty and Disclosures

Joseph H. Butterfield, MD FAAAAI

Joseph H. Butterfield, MD FAAAAI

No Conflict
Melody C. Carter, MD FAAAAI

Melody C. Carter, MD FAAAAI

No Conflict
Marco Cicardi, MD

Marco Cicardi, MD

Potential Conflict

Research Grant: Dyax
Research Grant: Shire
Consultant: Shire
Advisory Board: BioCryst
Advisory Board: CSL Behring
Speaker: CSL Behring
Kirk M. Druey, MD

Kirk M. Druey, MD

No Conflict
Paneez Khoury, MD

Paneez Khoury, MD

No Conflict
Bruce L. Zuraw, MD

Bruce L. Zuraw, MD

Potential Conflict

Consultant: BioCryst
Consultant: Ionis
Consultant: Alnylan
Consultant: Arrowhead
Consultant: BioCryst
Consultant: CSL Behring
Consultant: Dyax
Consultant: Ionis
Consultant: Nektar
Consultant: Shire
Genentech (Ongoing): Consultant
Novartis (Ongoing): Consultant
Sanofi-Aventis (Ongoing): Consultant
NIH (Ongoing): Research support
U.S. Department of Defense (Ongoing):
Research support
Veterans Administration (Ongoing):
Research support
--------------------------------------------------
HAE Association (Ongoing): Chair of
Medical Advisory Board and HAE Registry

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error